antibody-based diagnostics
Antibody assays cannot be used for a SARS-CoV-2 diagnosis, but some evidence is emerging that they could eventually detect immunity from the infection.
WHO Inks License Agreement for Commercialization, Manufacturing of COVID-19 Antibody Test Technology
One of the tests can distinguish the immune response of individuals who were infected with SARS-CoV-2 from those who were vaccinated.
GS Labs Sues Insurer Medica for COVID-19 Rapid Test Reimbursement
GS Labs is alleging that Medica, in violation of the CARES Act, showed disregard for the rights and safety of insured members in need of COVID-19 testing.
Newly Nonprofit Mologic Accelerates Work on Neglected Disease Tests, Affordable COVID-19 Assays
Premium
The firm is developing a SARS-CoV-2 antigen test that could cost $2 or less while working on lateral flow assays for several neglected diseases.
The firm anticipates regulatory submissions or clearances for 10 additional POC tests within the next two years including for troponin, COVID/flu, and tuberculosis.